We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,452.87%
AUM
$2.91B
AUM Growth
-$322M
Cap. Flow
-$466M
Cap. Flow %
-16.01%
Top 10 Hldgs %
16.3%
Holding
266
New
11
Increased
65
Reduced
149
Closed
26

Sector Composition

Rank Sector Weight
1 Technology 33.61%
2 Healthcare 20.94%
3 Industrials 10.75%
4 Financials 6.48%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTI
1
DELISTED
Ultimate Software Group Inc
ULTI
$57.5M 1.98%
293,927
-49,229
-14% -$9.64M
ABCO
2
DELISTED
Advisory Board Co
ABCO
$54.6M 1.88%
1,099,806
+475
+0% +$23.1K
CSGP icon
3
CoStar Group
CSGP
$12.2B
$53.1M 1.83%
2,569,020
-337,010
-12% -$6.71M
SPSC icon
4
SPS Commerce
SPSC
$2.58B
$52.9M 1.82%
1,507,058
-176,098
-10% -$6.43M
DWRE
5
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$49.7M 1.71%
921,257
+233,189
+34% +$12.2M
AMG icon
6
Affiliated Managers Group
AMG
$9.67B
$48M 1.65%
300,223
-27,100
-8% -$4.66M
TWOU
7
DELISTED
2U Inc
TWOU
$42.3M 1.46%
50,414
+17,656
+54% +$13.2M
EEFT icon
8
Euronet Worldwide
EEFT
$3.17B
$40.7M 1.4%
561,433
-181,352
-24% -$13.9M
LGND icon
9
Ligand Pharmaceuticals
LGND
$5.79B
$38.9M 1.34%
574,874
-51,899
-8% -$3.2M
SMCI icon
10
Super Micro Computer
SMCI
$17.3B
$36.2M 1.25%
14,778,780
-1,243,650
-8% -$3.25M
RBC icon
11
RBC Bearings
RBC
$17.6B
$35.5M 1.22%
549,113
-51,946
-9% -$3.47M
NKTR icon
12
Nektar Therapeutics
NKTR
$2.3B
$35.1M 1.21%
138,810
-15,835
-10% -$3.26M
CYNO
13
DELISTED
Cynosure, Inc. Class A
CYNO
$34.3M 1.18%
767,992
+7,451
+1% +$283K
IMAX icon
14
IMAX
IMAX
$2.6B
$34.2M 1.18%
961,983
-323,744
-25% -$12.1M
BLOX
15
DELISTED
Infoblox Inc
BLOX
$33.4M 1.15%
1,817,801
-193,082
-10% -$3.27M
GIMO
16
DELISTED
Gigamon Inc.
GIMO
$33M 1.14%
1,243,322
-118,290
-9% -$3.04M
WST icon
17
West Pharmaceutical
WST
$23.5B
$32.6M 1.12%
541,410
-122,990
-19% -$7.4M
JBTM
18
JBT Marel
JBTM
$7.26B
$32.4M 1.11%
650,557
-128,791
-17% -$5.85M
RKUS
19
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$32.2M 1.11%
3,002,399
-459,174
-13% -$5.34M
XLRN
20
DELISTED
Acceleron Pharma
XLRN
$32M 1.1%
656,391
+165,955
+34% +$5.97M
RHT
21
DELISTED
Red Hat Inc
RHT
$31.8M 1.09%
384,176
-100,924
-21% -$8.01M
BIO icon
22
Bio-Rad Laboratories Class A
BIO
$8.78B
$29.6M 1.02%
213,434
-24,600
-10% -$3.41M
AXON
23
Axon Enterprise
AXON
$44.4B
$29.3M 1.01%
1,694,872
+112,486
+7% +$2.25M
QGENF
24
DELISTED
QIAGEN NV
QGENF
$29.1M 1%
1,051,000
ALKS icon
25
Alkermes
ALKS
$8.11B
$28.8M 0.99%
362,500
-201,000
-36% -$14.1M

Similar funds

Granahan Investment Management's Q4 2015 Portfolio in Review

As of Q4 2015, Granahan Investment Management held 266 positions worth $2.91B, down 10% from $3.23B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granahan Investment Management withdrew a net $466M in Q4 2015, closing 26 positions and reducing 149 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $33.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Ionis Pharmaceuticals worth $13.1M.

  • Granahan Investment Management's largest Q4 2015 buy was Ionis Pharmaceuticals: 212,000 shares worth $13.1M.
  • Granahan Investment Management added most to Abiomed Inc in Q4 2015, an estimated $18M increase.
  • Granahan Investment Management's biggest Q4 2015 reduction was Crocs, cutting an estimated $20.8M.
  • Granahan Investment Management fully exited iShares Russell 2000 Growth ETF in Q4 2015, selling an estimated $33.5M.
  • Granahan Investment Management's ten largest holdings make up 16% of its $2.91B portfolio in Q4 2015.
  • Granahan Investment Management opened 11 new positions and closed 26 in Q4 2015.
  • Granahan Investment Management's portfolio value fell 10% quarter-over-quarter to $2.91B.

Based on Granahan Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.